Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propafenone in Septic Shock (PRASE)
NCT03029169Phase 4Completed
- Sponsor
- Charles University
- Start
- Oct 2017
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of propafenone in Supraventricular arrhythmia (SVA), sponsored by Charles University. Started Oct 2017; status: completed.
02
Drugs
propafenone
03
Conditions
Supraventricular arrhythmia (SVA)
Beyond the preview
Go deeper on NCT03029169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03029169.